eli lilly glp-1 receptor agonist products FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly's Zepbound available in
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9

























